CellVec Pte Ltd
CellVec is a gene therapy CDMO and a specialist provider of Lentiviral vectors for early to pivotal phase clinical development. CellVec’s R&D interests spans from vector system biology to novel stable cell line development and downstream purification technologies to generate high yield, high titre regulatory compliant viral vectors for clinical gene therapy. Our new state of the art GMP Manufacturing Facility and PQS are regulated by Singapore’s Health Science Authority (HSA) and compliant to PIC/S, EU GMP and US FDA requirements. CellVec’s expertise supports Process Development with a custom approach to ensure our client’s requirements are delivered in a high quality, timely and regulatory compliant manner.